Virtu KCG Holdings’s ResMed RMD Stock Holding History

Virtu KCG Holdings’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-4,000	Closed	-$225K	–	3735
2015 Q2	$225K	Buy	4,000 +100	+3%	+$6.31K	﹤0.01%	2438
2015 Q1	$280K	Buy	+3,900	New	+$253K	0.01%	1993

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu KCG Holdings's RMD Position: Q2 2017 in Review

Virtu KCG Holdings sold out of ResMed (RMD) in Q2 2017, closing a stake of 3,718 shares — an estimated $268K sold.

Virtu KCG Holdings first reported a position in RMD in Q3 2013 and held it in 10 quarters. The position peaked at $1.26M in Q3 2016. 340 funds tracked by Wall St. Rank hold RMD as of Q2 2017.

Virtu KCG Holdings reported no remaining ResMed position as of Q2 2017 after selling out during the quarter.
Virtu KCG Holdings sold 3,718 ResMed shares in Q2 2017, an estimated $268K.
Virtu KCG Holdings first reported a position in ResMed in Q3 2013 and held it in 10 quarters.
Virtu KCG Holdings's ResMed position peaked at $1.26M in Q3 2016.
340 funds tracked by Wall St. Rank held ResMed as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.